CC
CORZ icon

Conversant Capital’s Core Scientific CORZ Stock Holding History

Conversant Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,950,000
Closed -$18.1M – 21
2024
Q2 		$18.1M Buy
+1,950,000
New +$9.96M 3.29% 11

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Conversant Capital's CORZ Position: Q3 2024 in Review

Conversant Capital sold out of Core Scientific (CORZ) in Q3 2024, closing a stake of 1,950,000 shares — an estimated $18.1M sold.

Conversant Capital first reported a position in CORZ in Q2 2024 and held it in 1 quarter. The position peaked at $18.1M in Q2 2024. 249 funds tracked by Wall St. Rank hold CORZ as of Q3 2024.

  • Conversant Capital reported no remaining Core Scientific position as of Q3 2024 after selling out during the quarter.
  • Conversant Capital sold 1,950,000 Core Scientific shares in Q3 2024, an estimated $18.1M.
  • Conversant Capital first reported a position in Core Scientific in Q2 2024 and held it in 1 quarter.
  • Conversant Capital's Core Scientific position peaked at $18.1M in Q2 2024.
  • 249 funds tracked by Wall St. Rank held Core Scientific as of Q3 2024.

Based on Conversant Capital's 13F filing for Q3 2024, filed 14 Nov 2024.